Maureen Jane
Miller, MD, MPH
Staff Clinician, Infectious Diseases Section
301-827-6645
Dr. Miller is a board-certified transfusion medicine pathologist.
MD, New York University, New York, NY
MPH, T.H. Chan Harvard School of Public Health, Boston, MA
Dr. Miller graduated from New York University School of Medicine and T.H. Chan Harvard School of Public Health in 2014. She completed residency training in anatomic and clinical pathology at NYU Langone Medical Center and Bellevue Hospital Center in New York City from 2014-2018 and a clinical fellowship in transfusion medicine and blood banking at the Emory Department of Pathology Center for Transfusion and Cellular Therapies in Atlanta, Georgia from 2018-2019. Following her clinical training, she completed a 2-year non-clinical fellowship in applied epidemiology at the Atlanta headquarters of the U.S. Centers for Disease Control and Prevention (CDC) As an officer in the agency's Epidemic Intelligence Service (EIS) of global health "disease detectives," Dr. Miller was assigned to the Division of Cancer Prevention and Control and the agency's emergency responses to COVID-19 and Mpox, where she led and contributed to multiple high-impact scientific publications and presentations disseminated widely in the international scientific community and media. In December 2022, Dr. Miller came from CDC to NIH to continue work as a clinical researcher of transfusion-transmitted infections among blood donors.
At NIH DTM, Dr. Miller is a staff clinician in the Infectious Disease Section (IDS) which includes the Transfusion-Transmitted Viruses (TTV) Operations Laboratory and a Research Group conducting a large-scale, investigator-initiated, and collaborative research program. She is responsible for providing medical consultation and support to IDS as it provides expert care to patients. Dr. Miller provides transfusion service consultative services and teach transfusion medicine to the clinical fellows.
In addition to her clinical role, Dr. Miller is a researcher developing and executing clinical research protocols. Dr. Miller's research interests are in the area of transfusion-transmitted diseases and other conditions related to emerging and re-emerging infections in the blood supply, including monitoring the changing epidemiology (e.g., seasonality, prevalence) of transfusion-transmitted infections in the population of healthy donors to the NIH Blood Bank using biological and clinical data collected from these donors. She is the principal investigator for several new IDS clinical research protocols that will study the potential relationship of the emergent tickborne allergic condition alpha-gal syndrome to blood donation and transfusion. To date, Dr. Miller has authored and co-authored over 35 peer-reviewed journal articles on various topics in Transfusion Medicine, with additional publications on medical training in national magazines. She is a peer reviewer for multiple high-impact medical journals and a member of the DTM Scientific Review Committee and NIH CC Hospital Infections Committee.
- CDC/ATSDR COVID-19 Response Honor Awards, 2021
- Excellence in Epidemiology – Domestic
- Excellence in Emergency Response: Toby Merlin Award - Domestic
- Bachelor of Arts with distinction in the history major, Yale University, 2006
- John Hersey award for outstanding undergraduate non-fiction writing, Yale University Department of English, 2005
Miller MJ, Long JO, Conry-Cantilena K, Chen LN, West-Mitchell KA, De Giorgi V. Seasonal increase in syphilis screening reactivity rates in whole blood donors, United States, 2011-2023. Transfusion. 2024 Jul 5. doi: 10.1111/trf.17951. Epub ahead of print. PMID: 38966907.
Miller MJ, Lee P, Lee BG, Flegel WA, West-Mitchell K, Conry-Cantilena K, De Giorgi V. Consideration for alpha-gal syndrome in two critically ill persons with group O blood who received group B plasma. Transfusion. 2024 May;64(5):949-951. doi: 10.1111/trf.17811. Epub 2024 Apr 3. PMID: 38566573; PMCID: PMC11104486.
Miller MJ, Perinet L, Alter HJ, Conry-Cantilena K, De Giorgi V. Natural History Studies, a Natural Next Step to Study Emerging Transfusion-Transmitted Infections. Transfus Med Rev. 2024 Apr;38(2):150820. doi: 10.1016/j.tmrv.2024.150820. Epub 2024 Jan 17. PMID: 38364616; PMCID: PMC11094804.
Godino JG, Samaniego JC, Sharp SP, Taren D, Zuber A, Armistad AJ, Dezan AM, Leyba AJ, Friedly JL, Bunnell AE, Matthews E, Miller MJ, Unger ER, Bertolli J, Hinckley A, Lin JS, Scott JD, Struminger BB, Ramers C. A technology-enabled multi-disciplinary team-based care model for the management of Long COVID and other fatiguing illnesses within a federally qualified health center: protocol for a two-arm, single-blind, pragmatic, quality improvement professional cluster randomized controlled trial. Trials. 2023 Aug 12;24(1):524. doi: 10.1186/s13063-023-07550-3. PMID: 37573421; PMCID: PMC10423413.
Long J, Soni M, Muranski P, Miller MJ, Conry-Cantilena C, De Giorgi V. Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient. Front Immunol. 2023 Jul 3;14:1207638. doi: 10.3389/fimmu.2023.1207638. PMID: 37465681; PMCID: PMC10350526.
Miller MJ. The Mould That Changed the World-A Musical Paean to Penicillin. JAMA. 2023 May 23;329(20):1719-1721. doi: 10.1001/jama.2023.7306. PMID: 37126319.
Miller MJ, Feldstein LR, Holbrook J, Plumb ID, Accorsi EK, Zhang QC, Cheng Q, Ko JY, Wanga V, Konkle S, Dimitrov LV, Bertolli J, Saydah S. Post-COVID conditions and healthcare utilization among adults with and without disabilities-2021 Porter Novelli FallStyles survey. Disabil Health J. 2023 Apr;16(2):101436. doi: 10.1016/j.dhjo.2022.101436. Epub 2022 Dec 19. PMID: 36740547; PMCID: PMC9762038.
Miller MJ, Cash-Goldwasser S, Marx GE, et al. Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(44):1412-1417. Published 2022 Nov 4. doi:10.15585/mmwr.mm7144e1.
Miller MJ, Fitch N, Himschoot A, et al. Association of Trends in SARS-CoV-2 Seroprevalence and Non-Pharmaceutical Interventions—August 1, 2020 – March 30, 2021. Clinical Infectious Diseases, 2022 Jun 10:ciac469. doi: 10.1093/cid/ciac469.
Fink R, Fisher L, Sulaeman H, Miller MJ et al. How do I… form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry? Transfusion. 24 May 2022. doi: 10.1111/trf.16943.
Miller MJ, Skrzekut A, Kracalik I, Jones JM, Lofy KH, Konkle BA, Haley NR, Duvenhage M, Bonnett T, Holbrook M, Higgs E, Basavaraju S, Paranjape S. How do I… facilitate a rapid response to a public health emergency requiring plasma collection with a public-private partnership? Transfusion 61(10):2814-2824, 4 October 2021. doi: 10.1111/trf.16630.
Jones JM, Stone M, Sulaeman H, Miller MJ, et al. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021. JAMA. 2021;326(14):1400–1409. doi:10.1001/jama.2021.15161.
Miller MJ, Xu L, Qin J, et al. Impact of COVID-19 on cervical cancer screening rates among women aged 21–65 years in a large integrated health care system — Southern California, January 1–September 30, 2019, and January 1–September 30, 2020. MMWR Morb Mortal Wkly Rep 2021;70:109–13.
Lancelot M, Miller MJ, Roback JD, Stowell SR. Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy. Transfusion. ePub 29 Oct 2020. https://doi.org/10.1111/trf.16117.
Miller MJ, McVoy L, Rapkiewicz A. Educational Case: Babesiosis and Transfusion-Transmitted Infections. Acad Pathol. 2020 Jul 17;7:2374289520935591. doi: 10.1177/2374289520935591. eCollection 2020 Jan-Dec. PMID: 32733991.
Moosavi H, Ma Y, Miller MJ, Duncan A. Transfusion. Validation of PLASMIC score: an academic medical center case series (2012-present). 2020 Jul;60(7):1536-1543. doi: 10.1111/trf.15916. Epub 2020 Jun 26. PMID: 32588918.
Bajema KL, Oster AM, McGovern OL, Lindstrom S, Stenger MR, Anderson TC, Isenhour C, Clarke KR, Evans ME, Chu VT, Biggs HM, Kirking HL, Gerber SI, Hall AJ, Fry AM, Oliver SE; (2019-nCoV Persons Under Investigation Team: Miller M). Persons Evaluated for 2019 Novel Coronavirus – United States, January 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):166-170. doi: 10.15585/mmwr.mm6906e1. PMID: 32053579.
Perrine CG et al. (Lung Injury Response Epidemiology/Surveillance Group: Miller M). Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping – United States, 2019. MMWR Morb Mortal Wkly Rep. 2019 Oct 4;68(39):860-864.